3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Pancreatic Neoplasms
9
Carcinoma, Non-Small-Cell Lung
8
Neoplasms
4
Breast Neoplasms
4
Lung Neoplasms
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Platinum-Refractory Fallopian Tube Carcinoma
2
Inflammatory Breast Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Teratoma, Testicular
1
Teratoma, Ovarian
1
Teratoma
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Recurrent Bladder Urothelial Carcinoma
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms, Unknown Primary
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Laryngeal Neoplasms
1
Interventions
eribulin
1
balixafortide
1
Taxes
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Advanced Breast Cancer
×
Taxes
×
Clear all
NCT04826016
2023-03-20
POLTER
MedSIR
Phase 1/2
Withdrawn